PMID- 36259254 OWN - NLM STAT- MEDLINE DCOM- 20230214 LR - 20230214 IS - 1365-2362 (Electronic) IS - 0014-2972 (Linking) VI - 53 IP - 3 DP - 2023 Mar TI - Psychiatric disorders and Type 2 diabetes mellitus: A bidirectional Mendelian randomization. PG - e13893 LID - 10.1111/eci.13893 [doi] AB - BACKGROUND: Extensive observational evidence put forward the association between psychiatric disorders and type 2 diabetes mellitus (T2DM). However, causal relationships between these two diseases required further research. Thus, we evaluated the bidirection casual effect between five psychiatric disorders and T2DM using two-sample mendelian randomization (MR). METHODS: By selecting single nucleotide polymorphisms associated with T2DM and five psychiatric disorders (attention-deficit hyperactivity disorder (ADHD), major depressive disorder (MDD), schizophrenia, anxiety disorder and panic disorder), a bidirectional two-sample MR was applied to evaluate causality between these diseases. The inverse-variance weighted (IVW) method was used as the primary analysing approach for estimating possible causal effects. MR-Egger and weighted median were also conducted to verify the results. The funnel plot, Cochran's Q test and MR-Egger intercept test were used for sensitivity analyses. In addition, potential mediators were investigated by risk factor analyses. RESULTS: Genetic susceptibilities of ADHD and MDD would increase the risk of T2DM (ADHD: OR = 1.14, 95%CI 1.08-1.20; p = 5.7 x 10-6 ; MDD: OR = 1.22, 95%CI 1.09-1.36; p = 0.0004 ). In addition, genetic predisposition to T2DM was also associated with ADHD (OR = 1.09, 95%CI 1.04-1.14; p = 0.0004). Several risk factors of T2DM were implicated in the above causal associations, including smoking, high body mass index, waist-to-hip ratio and elevated serum triglycerides. CONCLUSION: Our studies indicated a causal effect of ADHD and MDD on increasing the risk of T2DM, which was potentially mediated by smoking and obesity-related phenotypes. Meanwhile, we found a causal effect of T2DM on ADHD. Thus, prevention strategies for T2DM should also include mental health and vice versa. CI - (c) 2022 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd. FAU - Tao, Haoran AU - Tao H AUID- ORCID: 0000-0001-6915-3038 AD - Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. AD - Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou key laboratory for Metabolic Diseases, Guangzhou, China. FAU - Fan, Shujin AU - Fan S AD - Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. AD - Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou key laboratory for Metabolic Diseases, Guangzhou, China. FAU - Zhu, Tianxin AU - Zhu T AD - Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. AD - Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou key laboratory for Metabolic Diseases, Guangzhou, China. FAU - You, Lili AU - You L AUID- ORCID: 0000-0001-6815-5939 AD - Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. AD - Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou key laboratory for Metabolic Diseases, Guangzhou, China. FAU - Zheng, Dinghao AU - Zheng D AD - Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. AD - Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou key laboratory for Metabolic Diseases, Guangzhou, China. FAU - Yan, Li AU - Yan L AD - Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. AD - Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou key laboratory for Metabolic Diseases, Guangzhou, China. FAU - Ren, Meng AU - Ren M AUID- ORCID: 0000-0001-9935-1449 AD - Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. AD - Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou key laboratory for Metabolic Diseases, Guangzhou, China. LA - eng GR - 2020B1111170009/Guangdong Clinical Research Center for Metabolic Diseases/ GR - 202102100004/Guangzhou key laboratory for Metabolic Diseases/ GR - U20A20352/National Natural Science Foundation of China-Guangdong Joint Fund/ PT - Journal Article DEP - 20221108 PL - England TA - Eur J Clin Invest JT - European journal of clinical investigation JID - 0245331 SB - IM MH - Humans MH - *Diabetes Mellitus, Type 2/epidemiology/genetics/complications MH - *Depressive Disorder, Major/epidemiology/genetics/complications MH - Mendelian Randomization Analysis/methods MH - Risk Factors MH - *Attention Deficit Disorder with Hyperactivity/epidemiology/genetics/complications MH - Polymorphism, Single Nucleotide OTO - NOTNLM OT - attention-deficit hyperactivity disorder OT - diabetes OT - mendelian randomization OT - psychiatric disorders EDAT- 2022/10/20 06:00 MHDA- 2023/02/15 06:00 CRDT- 2022/10/19 04:03 PHST- 2022/10/11 00:00 [revised] PHST- 2022/09/10 00:00 [received] PHST- 2022/10/17 00:00 [accepted] PHST- 2022/10/20 06:00 [pubmed] PHST- 2023/02/15 06:00 [medline] PHST- 2022/10/19 04:03 [entrez] AID - 10.1111/eci.13893 [doi] PST - ppublish SO - Eur J Clin Invest. 2023 Mar;53(3):e13893. doi: 10.1111/eci.13893. Epub 2022 Nov 8.